CareDx Inc reports results for the quarter ended in September 30 - Earnings Summary

CareDx

05/11/2024 08:01

* CareDx Inc  CDNA.OQ  reported quarterly adjusted earnings
of 14
cents​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of -18 cents.  The mean expectation of nine analysts for the
quarter was for earnings of one cent per share. Wall Street
expected results to range from -2 cents to 6 cents per share.
    * Revenue rose 23.4% to $82.88 million from a year ago;
analysts
expected $80.53 million. 
    * CareDx Inc's reported EPS for the quarter was a loss of 14
cents​.
    * The company reported a quarterly loss of $7.41 million.
    * CareDx Inc shares had fallen by 26.6% this quarter and
gained 91.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 498.8%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for CareDx Inc is
35.00 
This summary was machine generated from LSEG data November 5 at
08:00 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.01           0.14           Beat
 Jun. 30 2024      -0.14          0.25           Beat
 Mar. 31 2024      -0.21          -0.03          Beat
 Dec. 31 2023      -0.27          -0.17          Beat